723. Allogeneic Transplantation: Long-term Follow-up, Complications, and Disease Recurrence: Poster I

A Phase 1B 2A study of weekly decitabine and venetoclax treatment as maintenance therapy in high risk myeloid malignancy patients post allogeneic stem cell transplantation

Limitations of the IWG MRT ELN response criteria in defining post transplant remission and clinical success in patients with myelofibrosis A retrospective study

Upfront vs posttherapy allogeneic stem cell transplantation for high risk myelodysplastic syndrome – a real world analysis in the era of molecular risk stratification

Efficacy of low dose rituximab as preemptive treatment of EBV DNA emia after allogeneic hematopoietic stem cell transplantation

Impact of angiotensin converting enzyme inhibitors ACEis or angiotensin II receptor blockers ARBs on kidney functions in allogeneic stem cell transplant patients receiving tacrolimus

Vancomycin resistant enterococci VRE colonization is associated with worse outcomes post allogenic hemopoietic stem cell transplantation

Optimizing letermovir timing Day 5 to 8 post haplo HSCT minimizes EBV dnaemia without compromising CMV prophylaxis

Azacitidine monotherapy versus combination regimens as post allogeneic transplantation maintenance in high risk myeloid malignancies A retrospective cohort Study

The impact of HLA loss of heterozygosity on outcome after haploidentical hematopoietic stem cell transplantation in hematological malignancies

Psychosocial well being in patients undergoing allogeneic hematopoietic stem cell transplantation allo HSCT and their caregivers A prospective study

Impact of HLA b leader matching status on prognosis and underlying mechanism in patients with hematological malignancies following haploidentical hematopoietic stem cell transplantation

Post transplant cyclophosphamide vs tacrolimus methotrexate Improved GRFS reduced NRM and less severe GVHD in myeloablative HLA matched allogeneic transplantation

Multi hit TP53 mutation is an independent adverse prognostic factor in allogeneic hematopoietic stem cell transplantation for acute leukemia and myelodysplastic syndromes

Blinatumomab improves erythroid engraftment in major incompatible ABO group hematopoietic stem cell transplantation

Allogeneic hematopoietic cell transplantation in dyskeratosis congenita Short and long term outcome of 183 consecutive patients transplanted at EBMT centers

A novel structured peer support intervention STEPP for patients undergoing hematopoietic stem cell transplantation A pilot randomized clinical trial

Cardiovascular disease risk scores as predictors of cardiovascular disease and heart failure in allogeneic hematopoietic cell transplant survivors

Mechanisms of immune escape and altered tissue homing in leukemia cutis

Association of CD34 cell dose on outcome after reduced intensity conditioning allogeneic peripheral blood stem cell transplantation PBSCT for adults with Acute Myeloid Leukemia AML in measurable residual disease MRD negative remission

Cost and quality of life analysis associated with allogeneic hematopoietic progenitor transplantation